182 related articles for article (PubMed ID: 26928235)
1. A Gene Gun-mediated Nonviral RNA trans-splicing Strategy for Col7a1 Repair.
Peking P; Koller U; Hainzl S; Kitzmueller S; Kocher T; Mayr E; Nyström A; Lener T; Reichelt J; Bauer JW; Murauer EM
Mol Ther Nucleic Acids; 2016 Mar; 5():e287. PubMed ID: 26928235
[TBL] [Abstract][Full Text] [Related]
2.
Liemberger B; Bischof J; Ablinger M; Hainzl S; Murauer EM; Lackner N; Ebner P; Kocher T; Nyström A; Wally V; Mayr E; Guttmann-Gruber C; Hofbauer JP; Bauer JW; Koller U
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901775
[TBL] [Abstract][Full Text] [Related]
3. 5'RNA
Mayr E; Ablinger M; Lettner T; Murauer EM; Guttmann-Gruber C; Piñón Hofbauer J; Hainzl S; Kaiser M; Klausegger A; Bauer JW; Koller U; Wally V
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163654
[TBL] [Abstract][Full Text] [Related]
4. Construction and validation of an RNA trans-splicing molecule suitable to repair a large number of COL7A1 mutations.
Tockner B; Kocher T; Hainzl S; Reichelt J; Bauer JW; Koller U; Murauer EM
Gene Ther; 2016 Nov; 23(11):775-784. PubMed ID: 27434145
[TBL] [Abstract][Full Text] [Related]
5. An RNA-targeted therapy for dystrophic epidermolysis bullosa.
Peking P; Koller U; Duarte B; Murillas R; Wolf S; Maetzig T; Rothe M; Kocher T; García M; Brachtl G; Schambach A; Larcher F; Reichelt J; Bauer JW; Murauer EM
Nucleic Acids Res; 2017 Sep; 45(17):10259-10269. PubMed ID: 28973459
[TBL] [Abstract][Full Text] [Related]
6. Compound heterozygosity for a recessive glycine substitution and a splice site mutation in the COL7A1 gene causes an unusually mild form of localized recessive dystrophic epidermolysis bullosa.
Terracina M; Posteraro P; Schubert M; Sonego G; Atzori F; Zambruno G; Bruckner-Tuderman L; Castiglia D
J Invest Dermatol; 1998 Nov; 111(5):744-50. PubMed ID: 9804332
[TBL] [Abstract][Full Text] [Related]
7. Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa.
Murauer EM; Gache Y; Gratz IK; Klausegger A; Muss W; Gruber C; Meneguzzi G; Hintner H; Bauer JW
J Invest Dermatol; 2011 Jan; 131(1):74-83. PubMed ID: 20720561
[TBL] [Abstract][Full Text] [Related]
8. Designing Efficient Double RNA trans-Splicing Molecules for Targeted RNA Repair.
Hüttner C; Murauer EM; Hainzl S; Kocher T; Neumayer A; Reichelt J; Bauer JW; Koller U
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669223
[TBL] [Abstract][Full Text] [Related]
9. Trans-splicing improvement by the combined application of antisense strategies.
Koller U; Hainzl S; Kocher T; Hüttner C; Klausegger A; Gruber C; Mayr E; Wally V; Bauer JW; Murauer EM
Int J Mol Sci; 2015 Jan; 16(1):1179-91. PubMed ID: 25569093
[TBL] [Abstract][Full Text] [Related]
10. Compound heterozygosity for a nonsense mutation and a splice site mutation in the type VII collagen gene (COL7A1) in recessive dystrophic epidermolysis bullosa.
Tamai K; Ishida-Yamamoto A; Matsuo S; Iizuka H; Hashimoto I; Christiano AM; Uitto J; McGrath JA
Lab Invest; 1997 Feb; 76(2):209-17. PubMed ID: 9042157
[TBL] [Abstract][Full Text] [Related]
11. Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa.
Goto M; Sawamura D; Ito K; Abe M; Nishie W; Sakai K; Shibaki A; Akiyama M; Shimizu H
J Invest Dermatol; 2006 Apr; 126(4):766-72. PubMed ID: 16439972
[TBL] [Abstract][Full Text] [Related]
12. Targeted Exon Skipping Restores Type VII Collagen Expression and Anchoring Fibril Formation in an In Vivo RDEB Model.
Turczynski S; Titeux M; Tonasso L; Décha A; Ishida-Yamamoto A; Hovnanian A
J Invest Dermatol; 2016 Dec; 136(12):2387-2395. PubMed ID: 27498345
[TBL] [Abstract][Full Text] [Related]
13. Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed Repair.
Izmiryan A; Ganier C; Bovolenta M; Schmitt A; Mavilio F; Hovnanian A
Mol Ther Nucleic Acids; 2018 Sep; 12():554-567. PubMed ID: 30195791
[TBL] [Abstract][Full Text] [Related]
14. A reporter-based screen to identify potent 3' trans-splicing molecules for endogenous RNA repair.
Murauer EM; Koller U; Hainzl S; Wally V; Bauer JW
Hum Gene Ther Methods; 2013 Feb; 24(1):19-27. PubMed ID: 23320616
[TBL] [Abstract][Full Text] [Related]
15. An ex vivo RNA trans-splicing strategy to correct human generalized severe epidermolysis bullosa simplex.
Peking P; Breitenbach JS; Ablinger M; Muss WH; Poetschke FJ; Kocher T; Koller U; Hainzl S; Kitzmueller S; Bauer JW; Reichelt J; Lettner T; Wally V
Br J Dermatol; 2019 Jan; 180(1):141-148. PubMed ID: 30099737
[TBL] [Abstract][Full Text] [Related]
16. Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa.
Heinonen S; Männikkö M; Klement JF; Whitaker-Menezes D; Murphy GF; Uitto J
J Cell Sci; 1999 Nov; 112 ( Pt 21)():3641-8. PubMed ID: 10523500
[TBL] [Abstract][Full Text] [Related]
17. Availability of mRNA Obtained from Peripheral Blood Mononuclear Cells for Testing Mutation Consequences in Dystrophic Epidermolysis Bullosa.
Akasaka E; Nakano H; Sawamura D
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948168
[TBL] [Abstract][Full Text] [Related]
18. A Case Report of an Infant with Autosomal Recessive Dystrophic Epidermolysis Bullosa: COL7A1 Gene Mutations at C2005T and G7922A.
Liu J; Wang L
Acta Dermatovenerol Croat; 2021 Dec; 29(3):164-166. PubMed ID: 34990346
[TBL] [Abstract][Full Text] [Related]
19. COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.
Hainzl S; Peking P; Kocher T; Murauer EM; Larcher F; Del Rio M; Duarte B; Steiner M; Klausegger A; Bauer JW; Reichelt J; Koller U
Mol Ther; 2017 Nov; 25(11):2573-2584. PubMed ID: 28800953
[TBL] [Abstract][Full Text] [Related]
20. Characterization of 18 new mutations in COL7A1 in recessive dystrophic epidermolysis bullosa provides evidence for distinct molecular mechanisms underlying defective anchoring fibril formation.
Hovnanian A; Rochat A; Bodemer C; Petit E; Rivers CA; Prost C; Fraitag S; Christiano AM; Uitto J; Lathrop M; Barrandon Y; de Prost Y
Am J Hum Genet; 1997 Sep; 61(3):599-610. PubMed ID: 9326325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
